Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. November 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas CEO John Timberlake to Participate as a Panelist on “Exploring Innovation in Diabetes Tech,” at DeviceTalks West Conference

BRIDGEWATER, N.J., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
26. November 2018 07:00 ET | Quelle: Valeritas, Inc.

Study Supports Valeritas’ V-Go® Can Improve Glycemic Control in Type 2 Patients When Using an Easy to Follow Physician-Driven Insulin Titration Algorithm

BRIDGEWATER, N.J., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
15. November 2018 20:13 ET | Quelle: Valeritas, Inc.

Valeritas Announces Pricing of $36 Million Public Offering

BRIDGEWATER, N.J., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
13. November 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas Signs Exclusive Middle East Distribution Agreement with Julphar

- V-Go distribution deals now span 14 countries and territories - BRIDGEWATER, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company, has...
12. November 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrated Improved Clinical and Economic Benefits Across Established BMI Strata in Patients with Type 2 Diabetes Including Those Overweight and Obese

BRIDGEWATER, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple,...
09. November 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas Reports Record Revenue for the Third Quarter 2018

- Company’s Third Consecutive Quarter with Greater than 30% Year-Over-Year Revenue Growth - BRIDGEWATER, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...
05. November 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas to Report Third Quarter 2018 Results November 9, 2018

BRIDGEWATER, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
19. Oktober 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas Announces That V-Go® Insulin Delivery Device Has Launched in Italy

BRIDGEWATER, N.J., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
17. Oktober 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas Wins Fifth Consecutive Cardinal Health Supply Chain Excellence Award

BRIDGEWATER, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
15. Oktober 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas Expects to Report Record Revenue for Third Quarter 2018

Third consecutive quarter with greater than 30% year-over-year revenue growth BRIDGEWATER, N.J., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology...

Vorherige Seite

Nächste Seite